RACHAEL HAWKINS-TIGHE: Open Payments
NPI 1689209207 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,567 in 146 payments from 21 companies in 2025. Trend: 2023 $1,699 · 2024 $2,485 · 2025 $2,567
Food & beverage: $2,504Education: $63
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $407 |
| Neurocrine BioSciences, Inc. | 19 | $332 |
| ABBVIE INC. | 17 | $201 |
| Vanda Pharmaceuticals Inc. | 9 | $201 |
| Alkermes, Inc. | 8 | $187 |
| Otsuka America Pharmaceutical, Inc. | 10 | $182 |
| Tris Pharma Inc | 8 | $143 |
| Supernus Pharmaceuticals, Inc. | 10 | $131 |
| Lundbeck LLC | 5 | $117 |
| HARMONY BIOSCIENCES LLC | 3 | $103 |
Products named: CAPLYTA, INGREZZA, REXULTI, VRAYLAR, FANAPT, Dyanavel XR, ARISTADA, Qelbree.
Industry payments across GA — which companies pay providers there.
